Liraglutide

Trade Name: 
Saxenda
Manufacturer/Distributor: 
Novo Nordisk
www.novonordisk.ca
Classification: 
Incretin mimetic
ATC Class: 
A10BX - other blood glucose lowering agents
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2015/02/26
Date Marketed in Canada (yyyy/mm/dd): 
2015/05/27
Presentation: 
Injection: 6 mg/mL DIN: 02437899
Comments: 
As an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with BMI of 30 kg/m2 or greater or 27 kg/m2 or greater in the presence of at least one comorbid condition (hypertension, diabetes or dyslipidemia) and who have failed previous weight management intervention.